新突破-话题@MedSci

#新突破#

217篇内容 | 3820人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1725037, encodeId=50a11e2503784, content=<a href='/topic/show?id=9ee758586bb' target=_blank style='color:#2F92EE;'>#新突破#</a>, objectTitle=基因治疗血红蛋白病新突破，7000种基因疾病有望治愈, objectType=article, longId=198192, objectId=e13c198192e0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e13c198192e0, replyNumber=0, likeNumber=37, createdTime=2020-11-23, rootId=0, userName=zxxiang, userId=792a33728807, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e13c198192e0, moduleTitle=基因治疗血红蛋白病新突破，7000种基因疾病有望治愈, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e13c198192e0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1725035, encodeId=ac181e2503573, content=<a href='/topic/show?id=9ee758586bb' target=_blank style='color:#2F92EE;'>#新突破#</a>, objectTitle=PNAS：新突破：阻断一种蛋白可抑制肝癌和胆管癌, objectType=article, longId=197119, objectId=823c19e11933, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=823c19e11933, replyNumber=0, likeNumber=94, createdTime=2020-11-18, rootId=0, userName=zxxiang, userId=792a33728807, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=823c19e11933, moduleTitle=PNAS：新突破：阻断一种蛋白可抑制肝癌和胆管癌, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=823c19e11933)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1725052, encodeId=fb8d1e2505295, content=<a href='/topic/show?id=9ee758586bb' target=_blank style='color:#2F92EE;'>#新突破#</a>, objectTitle=耐药性肺结核治疗迎来新突破，疗程或缩短三分之一！, objectType=article, longId=207521, objectId=31b020e521d3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=31b020e521d3, replyNumber=0, likeNumber=69, createdTime=2021-11-07, rootId=0, userName=zxxiang, userId=792a33728807, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=31b020e521d3, moduleTitle=耐药性肺结核治疗迎来新突破，疗程或缩短三分之一！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=31b020e521d3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1725039, encodeId=18641e2503955, content=<a href='/topic/show?id=9ee758586bb' target=_blank style='color:#2F92EE;'>#新突破#</a>, objectTitle=Cancer Dis：三阴性乳腺癌靶向治疗新突破！BBOX1基因是关键！, objectType=article, longId=198235, objectId=9ec619823514, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9ec619823514, replyNumber=0, likeNumber=64, createdTime=2021-01-27, rootId=0, userName=zxxiang, userId=792a33728807, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9ec619823514, moduleTitle=Cancer Dis：三阴性乳腺癌靶向治疗新突破！BBOX1基因是关键！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9ec619823514)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1725031, encodeId=5f6d1e2503107, content=<a href='/topic/show?id=9ee758586bb' target=_blank style='color:#2F92EE;'>#新突破#</a>, objectTitle=2020EAN学术热点回顾阿尔茨海默病诊断新突破, objectType=article, longId=195608, objectId=df2c19560844, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=df2c19560844, replyNumber=0, likeNumber=53, createdTime=2021-03-19, rootId=0, userName=zxxiang, userId=792a33728807, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=df2c19560844, moduleTitle=2020EAN学术热点回顾阿尔茨海默病诊断新突破, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=df2c19560844)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1725032, encodeId=1bcd1e25032af, content=<a href='/topic/show?id=9ee758586bb' target=_blank style='color:#2F92EE;'>#新突破#</a>, objectTitle=第三代宫颈癌疫苗研究又获新突破，HPV疫苗打这一针就够了, objectType=article, longId=195628, objectId=1e681956287d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1e681956287d, replyNumber=0, likeNumber=76, createdTime=2021-05-02, rootId=0, userName=zxxiang, userId=792a33728807, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1e681956287d, moduleTitle=第三代宫颈癌疫苗研究又获新突破，HPV疫苗打这一针就够了, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1e681956287d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1725042, encodeId=bf441e25042a8, content=<a href='/topic/show?id=9ee758586bb' target=_blank style='color:#2F92EE;'>#新突破#</a>, objectTitle=基石药业舒格利单抗一线数据亮相ESMO，胃癌、食管鳞癌再迎新突破, objectType=article, longId=201028, objectId=cf56201028f4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=cf56201028f4, replyNumber=0, likeNumber=64, createdTime=2021-02-10, rootId=0, userName=zxxiang, userId=792a33728807, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=cf56201028f4, moduleTitle=基石药业舒格利单抗一线数据亮相ESMO，胃癌、食管鳞癌再迎新突破, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=cf56201028f4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1725020, encodeId=36d11e25020d2, content=<a href='/topic/show?id=9ee758586bb' target=_blank style='color:#2F92EE;'>#新突破#</a>, objectTitle=新突破！中国新冠病毒灭活疫苗获批进入临床试验, objectType=article, longId=192264, objectId=498f192264bc, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=498f192264bc, replyNumber=0, likeNumber=63, createdTime=2020-04-15, rootId=0, userName=zxxiang, userId=792a33728807, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=498f192264bc, moduleTitle=新突破！中国新冠病毒灭活疫苗获批进入临床试验, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=498f192264bc)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1725025, encodeId=efb11e250251f, content=<a href='/topic/show?id=9ee758586bb' target=_blank style='color:#2F92EE;'>#新突破#</a>, objectTitle=JAK1抑制剂新突破！溃疡性结肠炎新药filgotinib达到试验主要终点, objectType=article, longId=194505, objectId=e08f19450510, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e08f19450510, replyNumber=0, likeNumber=60, createdTime=2021-03-13, rootId=0, userName=zxxiang, userId=792a33728807, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e08f19450510, moduleTitle=JAK1抑制剂新突破！溃疡性结肠炎新药filgotinib达到试验主要终点, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e08f19450510)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1725030, encodeId=ff611e2503061, content=<a href='/topic/show?id=9ee758586bb' target=_blank style='color:#2F92EE;'>#新突破#</a>, objectTitle=【Nature】头秃星人留下感动的泪水！再生医学新突破！, objectType=article, longId=195558, objectId=5e8319555825, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5e8319555825, replyNumber=0, likeNumber=54, createdTime=2020-08-01, rootId=0, userName=zxxiang, userId=792a33728807, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5e8319555825, moduleTitle=【Nature】头秃星人留下感动的泪水！再生医学新突破！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5e8319555825)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1725034, encodeId=fbf21e2503461, content=<a href='/topic/show?id=9ee758586bb' target=_blank style='color:#2F92EE;'>#新突破#</a>, objectTitle=天使人综合征的治疗迎来新突破！FDA授予OV101孤儿药称号, objectType=article, longId=196222, objectId=4244196222ff, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4244196222ff, replyNumber=0, likeNumber=79, createdTime=2021-04-27, rootId=0, userName=zxxiang, userId=792a33728807, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4244196222ff, moduleTitle=天使人综合征的治疗迎来新突破！FDA授予OV101孤儿药称号, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4244196222ff)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1725027, encodeId=baa51e2502710, content=<a href='/topic/show?id=9ee758586bb' target=_blank style='color:#2F92EE;'>#新突破#</a>, objectTitle=ASCO 2020 | 肺鳞癌免疫治疗新突破，百济神州展现中国“研”值, objectType=article, longId=195059, objectId=f74a195059c2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f74a195059c2, replyNumber=0, likeNumber=87, createdTime=2020-10-24, rootId=0, userName=zxxiang, userId=792a33728807, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f74a195059c2, moduleTitle=ASCO 2020 | 肺鳞癌免疫治疗新突破，百济神州展现中国“研”值, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f74a195059c2)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1725045, encodeId=40b71e25045b6, content=<a href='/topic/show?id=9ee758586bb' target=_blank style='color:#2F92EE;'>#新突破#</a>, objectTitle=哮喘治疗新突破：IL-15Rα单抗FASENRA让62%的患者摆脱口服糖皮质激素, objectType=article, longId=202761, objectId=152c202e61d8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=152c202e61d8, replyNumber=0, likeNumber=68, createdTime=2021-05-07, rootId=0, userName=zxxiang, userId=792a33728807, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=152c202e61d8, moduleTitle=哮喘治疗新突破：IL-15Rα单抗FASENRA让62%的患者摆脱口服糖皮质激素, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=152c202e61d8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1725029, encodeId=e6e31e2502923, content=<a href='/topic/show?id=9ee758586bb' target=_blank style='color:#2F92EE;'>#新突破#</a>, objectTitle=复发难治肾细胞癌的治疗或迎新突破：FDA已批准Tivozanib的NDA, objectType=article, longId=195152, objectId=4ee01951523a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4ee01951523a, replyNumber=0, likeNumber=112, createdTime=2021-01-25, rootId=0, userName=zxxiang, userId=792a33728807, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4ee01951523a, moduleTitle=复发难治肾细胞癌的治疗或迎新突破：FDA已批准Tivozanib的NDA, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4ee01951523a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1725017, encodeId=27bd1e2501749, content=<a href='/topic/show?id=9ee758586bb' target=_blank style='color:#2F92EE;'>#新突破#</a>, objectTitle=靶向治疗取得新突破，肺癌将成慢性病, objectType=article, longId=182936, objectId=3aa21829362c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3aa21829362c, replyNumber=0, likeNumber=61, createdTime=2020-05-29, rootId=0, userName=zxxiang, userId=792a33728807, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3aa21829362c, moduleTitle=靶向治疗取得新突破，肺癌将成慢性病, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3aa21829362c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1725038, encodeId=f76f1e25038fa, content=<a href='/topic/show?id=9ee758586bb' target=_blank style='color:#2F92EE;'>#新突破#</a>, objectTitle=Cell封面 | David Liu再取新突破：不需要做实验，就能知道基因编辑的结果, objectType=article, longId=198227, objectId=721419822e0d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=721419822e0d, replyNumber=0, likeNumber=63, createdTime=2020-10-02, rootId=0, userName=zxxiang, userId=792a33728807, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=721419822e0d, moduleTitle=Cell封面 | David Liu再取新突破：不需要做实验，就能知道基因编辑的结果, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=721419822e0d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1725022, encodeId=65a51e2502260, content=<a href='/topic/show?id=9ee758586bb' target=_blank style='color:#2F92EE;'>#新突破#</a>, objectTitle=Nature：新突破：胰腺癌治疗新方法——羟化氯喹+化疗, objectType=article, longId=193051, objectId=fe3d193051d9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=fe3d193051d9, replyNumber=0, likeNumber=80, createdTime=2020-08-21, rootId=0, userName=zxxiang, userId=792a33728807, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=fe3d193051d9, moduleTitle=Nature：新突破：胰腺癌治疗新方法——羟化氯喹+化疗, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=fe3d193051d9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1725033, encodeId=d2241e25033ea, content=<a href='/topic/show?id=9ee758586bb' target=_blank style='color:#2F92EE;'>#新突破#</a>, objectTitle=Nature子刊：新突破：变胖莫担心，“燃烧”脂肪的分子来了！不需要锻炼和节食, objectType=article, longId=195737, objectId=2437195e37e4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2437195e37e4, replyNumber=0, likeNumber=83, createdTime=2020-10-23, rootId=0, userName=zxxiang, userId=792a33728807, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2437195e37e4, moduleTitle=Nature子刊：新突破：变胖莫担心，“燃烧”脂肪的分子来了！不需要锻炼和节食, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2437195e37e4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1725021, encodeId=99941e250218b, content=<a href='/topic/show?id=9ee758586bb' target=_blank style='color:#2F92EE;'>#新突破#</a>, objectTitle=Brain Stimul：孙伯民教授在难治性神经性厌食症手术治疗中获新突破, objectType=article, longId=192475, objectId=0f791924e58c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0f791924e58c, replyNumber=0, likeNumber=91, createdTime=2020-09-19, rootId=0, userName=zxxiang, userId=792a33728807, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0f791924e58c, moduleTitle=Brain Stimul：孙伯民教授在难治性神经性厌食症手术治疗中获新突破, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0f791924e58c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1725019, encodeId=3e3b1e2501922, content=<a href='/topic/show?id=9ee758586bb' target=_blank style='color:#2F92EE;'>#新突破#</a>, objectTitle=Sci Transl Med：转移性前列腺癌新突破：免疫检查点抑制剂彰显成效！, objectType=article, longId=191332, objectId=39b819133230, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=39b819133230, replyNumber=0, likeNumber=86, createdTime=2020-09-30, rootId=0, userName=zxxiang, userId=792a33728807, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=39b819133230, moduleTitle=Sci Transl Med：转移性前列腺癌新突破：免疫检查点抑制剂彰显成效！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=39b819133230)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

新突破

2020-05-29

zxxiang (审核中...)

前往app查看评论内容

#新突破#

基因治疗血红蛋白病新突破，7000种基因疾病有望治愈

2020-11-23

zxxiang (审核中...)

前往app查看评论内容

#新突破#

PNAS：新突破：阻断一种蛋白可抑制肝癌和胆管癌

2020-11-18

zxxiang (审核中...)

前往app查看评论内容

#新突破#

耐药性肺结核治疗迎来新突破，疗程或缩短三分之一！

2021-11-07

zxxiang (审核中...)

前往app查看评论内容

#新突破#

Cancer Dis：三阴性乳腺癌靶向治疗新突破！BBOX1基因是关键！

2021-01-27

zxxiang (审核中...)

前往app查看评论内容

#新突破#

2020EAN学术热点回顾阿尔茨海默病诊断新突破

2021-03-19

zxxiang (审核中...)

前往app查看评论内容

#新突破#

第三代宫颈癌疫苗研究又获新突破，HPV疫苗打这一针就够了

2021-05-02

zxxiang (审核中...)

前往app查看评论内容

#新突破#

基石药业舒格利单抗一线数据亮相ESMO，胃癌、食管鳞癌再迎新突破

2021-02-10

zxxiang (审核中...)

前往app查看评论内容

#新突破#

新突破！中国新冠病毒灭活疫苗获批进入临床试验

2020-04-15

zxxiang (审核中...)

前往app查看评论内容

#新突破#

JAK1抑制剂新突破！溃疡性结肠炎新药filgotinib达到试验主要终点

2021-03-13

zxxiang (审核中...)

前往app查看评论内容

#新突破#

【Nature】头秃星人留下感动的泪水！再生医学新突破！

2020-08-01

zxxiang (审核中...)

前往app查看评论内容

#新突破#

天使人综合征的治疗迎来新突破！FDA授予OV101孤儿药称号

2021-04-27

zxxiang (审核中...)

前往app查看评论内容

#新突破#

ASCO 2020 | 肺鳞癌免疫治疗新突破，百济神州展现中国“研”值

2020-10-24

zxxiang (审核中...)

前往app查看评论内容

#新突破#

哮喘治疗新突破：IL-15Rα单抗FASENRA让62%的患者摆脱口服糖皮质激素

2021-05-07

zxxiang (审核中...)

前往app查看评论内容

#新突破#

复发难治肾细胞癌的治疗或迎新突破：FDA已批准Tivozanib的NDA

2021-01-25

zxxiang (审核中...)

前往app查看评论内容

#新突破#

靶向治疗取得新突破，肺癌将成慢性病

2020-05-29

zxxiang (审核中...)

前往app查看评论内容

#新突破#

Cell封面 | David Liu再取新突破：不需要做实验，就能知道基因编辑的结果

2020-10-02

zxxiang (审核中...)

前往app查看评论内容

#新突破#

Nature：新突破：胰腺癌治疗新方法——羟化氯喹+化疗

2020-08-21

zxxiang (审核中...)

前往app查看评论内容

#新突破#

Nature子刊：新突破：变胖莫担心，“燃烧”脂肪的分子来了！不需要锻炼和节食

2020-10-23

zxxiang (审核中...)

前往app查看评论内容

#新突破#

Brain Stimul：孙伯民教授在难治性神经性厌食症手术治疗中获新突破

2020-09-19

zxxiang (审核中...)

前往app查看评论内容

#新突破#

Sci Transl Med：转移性前列腺癌新突破：免疫检查点抑制剂彰显成效！

2020-09-30

科室
- - 订阅+
  - 更多科室
工具
服务